BACKGROUND: The storage capacity of adipose tissue may be an important factor linking obesity, insulin resistance (IR), and associated morbidities. The aim of this study was to analyze the expression of lipogenic and lipolytic genes in adipose tissue and the influence of IR. METHODS: We studied the mRNA expression of peroxisome proliferator-activated receptor-γ (PPARγ) and lipogenic and lipolytic enzymes in the visceral (VAT) and subcutaneous adipose tissue (SAT) from 23 morbidly obese patients (MO; 13 with low IR and ten with high IR) and from 15 healthy, lean controls. RESULTS: In the VAT and SAT from the MO, we found an increased expression of PPARγ (p = 0.001 and p = 0.022, respectively), acyl-coenzyme A (CoA)/cholesterol acyltransferase (p < 0.001 and p < 0.001), aquaporin 7 (p < 0.001 and p = 0.003), and adipose triglyceride lipase (p < 0.001 and p < 0.001) and a reduced expression of acetyl-coenzyme A carboxylase (p = 0.004 and p < 0.001), independently of the state of IR. The expression of phosphoenolpyruvate carboxykinase and acyl-CoA synthetase, however, was significantly lower in the MO with high IR (p < 0.05). Glycerol kinase (p = 0.010), hormone-sensitive lipase (p < 0.001), and perilipin (p = 0.006) were only significantly increased in VAT. Acyl-CoA synthetase (p = 0.012) and fatty acid binding protein-4 (p = 0.003) were only significantly decreased in SAT. The expression of the genes studied was only greater in the SAT than the VAT in the controls. CONCLUSION: Our results show an upregulation of genes facilitating triglyceride/fatty acid cycling and a reduction in the genes involved in de novo synthesis of fatty acids in morbid obesity. The expression of some of the genes studied seems to be related with the state of IR. VAT and SAT differ metabolically and also between controls and MO.
BACKGROUND: The storage capacity of adipose tissue may be an important factor linking obesity, insulin resistance (IR), and associated morbidities. The aim of this study was to analyze the expression of lipogenic and lipolytic genes in adipose tissue and the influence of IR. METHODS: We studied the mRNA expression of peroxisome proliferator-activated receptor-γ (PPARγ) and lipogenic and lipolytic enzymes in the visceral (VAT) and subcutaneous adipose tissue (SAT) from 23 morbidly obesepatients (MO; 13 with low IR and ten with high IR) and from 15 healthy, lean controls. RESULTS: In the VAT and SAT from the MO, we found an increased expression of PPARγ (p = 0.001 and p = 0.022, respectively), acyl-coenzyme A (CoA)/cholesterol acyltransferase (p < 0.001 and p < 0.001), aquaporin 7 (p < 0.001 and p = 0.003), and adipose triglyceride lipase (p < 0.001 and p < 0.001) and a reduced expression of acetyl-coenzyme A carboxylase (p = 0.004 and p < 0.001), independently of the state of IR. The expression of phosphoenolpyruvate carboxykinase and acyl-CoA synthetase, however, was significantly lower in the MO with high IR (p < 0.05). Glycerol kinase (p = 0.010), hormone-sensitive lipase (p < 0.001), and perilipin (p = 0.006) were only significantly increased in VAT. Acyl-CoA synthetase (p = 0.012) and fatty acid binding protein-4 (p = 0.003) were only significantly decreased in SAT. The expression of the genes studied was only greater in the SAT than the VAT in the controls. CONCLUSION: Our results show an upregulation of genes facilitating triglyceride/fatty acid cycling and a reduction in the genes involved in de novo synthesis of fatty acids in morbid obesity. The expression of some of the genes studied seems to be related with the state of IR. VAT and SAT differ metabolically and also between controls and MO.
Authors: M Flechtner-Mors; C P Jenkinson; A Alt; H K Biesalski; G Adler; H H Ditschuneit Journal: J Physiol Pharmacol Date: 2005-09 Impact factor: 3.011
Authors: Eduardo Garcia-Fuentes; Mora Murri; Lourdes Garrido-Sanchez; Sara Garcia-Serrano; Jose M García-Almeida; Inmaculada Moreno-Santos; Francisco J Tinahones; Manuel Macias-Gonzalez Journal: Obesity (Silver Spring) Date: 2009-10-08 Impact factor: 5.002
Authors: Lourdes Garrido-Sánchez; Jose M García-Almeida; Sara García-Serrano; Isabel Cardona; Juan García-Arnes; Federico Soriguer; Francisco J Tinahones; Eduardo García-Fuentes Journal: Diabetes Care Date: 2008-10-03 Impact factor: 17.152
Authors: F Rodríguez-Pacheco; C Gutierrez-Repiso; S García-Serrano; A Ho-Plagaro; J M Gómez-Zumaquero; S Valdes; M Gonzalo; J Rivas-Becerra; C Montiel-Casado; G Rojo-Martínez; E García-Escobar; E García-Fuentes Journal: Int J Obes (Lond) Date: 2017-06-19 Impact factor: 5.095
Authors: Sara García-Serrano; Inmaculada Moreno-Santos; Lourdes Garrido-Sánchez; Carolina Gutierrez-Repiso; Jose M García-Almeida; Juan García-Arnés; Jose Rivas-Marín; Jose L Gallego-Perales; Eva García-Escobar; Gemma Rojo-Martinez; Francisco Tinahones; Federico Soriguer; Manuel Macias-Gonzalez; Eduardo García-Fuentes Journal: Mol Med Date: 2010-11-05 Impact factor: 6.354
Authors: P Mauriège; D R Joanisse; S CasparBauguil; A Cartier; I Lemieux; J Bergeron; S Biron; P Marceau; D Richard Journal: J Physiol Biochem Date: 2015-10-10 Impact factor: 4.158